Drugs.com - Pharma Industry News

AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof

FRIDAY, March 14, 2025 -- Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment, according to a study presented at the annual meeting of...

Mar 14, 2025 - 18:11
 0
AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof
FRIDAY, March 14, 2025 -- Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment, according to a study presented at the annual meeting of...
Read More

Tags:

Previous Article

COVID-19 Vaccination Not Linked to Major Structural Birth Defects

Next Article

U.S. Prevalence of Adverse CVD Outcomes Varies With Income, Education

Related Posts

Cumulative Epilepsy Risk Higher After Neonatal Seizures

Cumulative Epilepsy Risk Higher After Neonatal Seizures

Feb 24, 2025  0

Mental Health Disparities Seen Among Sexual, Gender Minority Populations

Mental Health Disparities Seen Among Sexual, Gender Min...

Feb 9, 2025  0

In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition

In 2023, 1.4 Percent of U.S. Children Ever Experienced ...

Feb 12, 2025  0